Ulcerative colitis continues to be a dangerous disease without completely satisfactory treatment. Knowledge of its aetiology is so limited that medical treatment has evolved solely by trial and error, and it is uncertain whether recent innovations in therapy have affected the long-term prognosis substantially. There is also controversy as to whether surgery, usually implying major procedures, should be employed extensively. Of the many complications of ulcerative colitis, cancer of the colon is known to be an appreciable risk after some years of the disease, but it is still not known whether this risk is so great that preventive colectomy is indicated.
Some of these issues were examined in a previous study of the patients with this disease seen at the Radcliffe Infirmary and Churchill Hospital, Oxford, during the 11-year period 1938-48 inclusive (RiceOxley and Truelove, 1950a and b) . The present study, which extends the period of observation until 1962, can be regarded as a continuation of the earlier work.
DATA
The primary sources of data were the case notes of all the patients with ulcerative colitis (including haemorrhagic proctitis) who were admitted to the Radcliffe Infirmary or to the Churchill Hospital from 1938 to March 1962 inclusive or who attended as out-patients during the same period. In the interests of brevity, we shall refer to these two hospitals as the Radcliffe Infirmary; and this is reasonable because they are under the same management, have a single records system, and the senior medical staff is common to both. 2 The diagnosis of ulcerative colitis was considered acceptable for the present study if the symptoms were compatible, the illness was not apparently caused by pathogenic bacteria, and sigmoidoscopy or barium enema (usually both) supported the diagnosis; in a very few cases, the diagnosis was made at necropsy.
A total of 624 patients fulfilled the diagnostic criteria just mentioned. Of these, 238 were currently attending the hospital and 75 were known to be already dead. A follow-up study has been made of the remaining 311 patients, using a variety of approaches, and it has proved possible to obtain adequate follow-up information about all of them. The follow-up enquiries took place during the five-month period ending 31 March 1962; continuation data have since been obtained on the latest entrants to the study, so that there is a minimum of a one-year follow-up in every case. In brief, there is reliable and up-to-date information in respect of 100% of the patients, the period of observation varying from one to 24 years, according to when they first attended the hospital.
In order to determine as completely as possible the progress of the disease up to the end of the study or until death, we have obtained reports from all other hospitals to which the patients were admitted, and from family doctors and specialists, to supplement the original questionnaire sent to every patient not currently attending our own hospital. In the case of patients who have died we know the certified cause of death in every instance; and whenever a post-mortem examination was made, we have obtained the pathologist's report. It would have been impossible to obtain such a 99 complete picture of the course of this illness without the active assistance of a large number of individuals and institutions, both lay and medical, and it is a pleasure to acknowledge their help. We are also grateful to the physicians and surgeons of the Radcliffe Infirmary for allowing us to include their patients in this study -so that it embraces the total experience of the hospital.
In order to analyse the extensive data at our disposal, we have transferred all the relevant clinical information obtained from the case histories and the follow-up on to punched cards for mechanical sorting. We shall now consider the results under four main headings: 1 Short-term prognosis, 2 long-term prognosis, 3 complications, and 4 carcinoma of the colon.
Part 1 Short-term prognosis
We shall consider here the immediate outcome of the attack of ulcerative colitis which first brought the patient to the Radcliffe Infirmary. When dealing with a disease which can pursue either an intermittent or continuous course over many years, which may never recur after the original attack, or which may terminate fatally in that attack, bias may be introduced for several reasons if all such cases are considered together, and much valuable information will remain hidden. We have therefore made an initial separation of the patients into two groups: those who were referred in their first attack of ulcerative colitis ('first attack group') and those who were referred because of a relapse of established disease ('relapse group'). For the purpose of this study, any patient who had had continuous symptoms for more than 12 months from the onset of the disease up to the time of referral was included in the relapse group. For the most part, the results of the analysis are presented separately for these two main groups. Table I shows the composition of the series. It shows that there were approximately 50% more women than men, and this applies equally to the Table III shows the duration of the disease before referral to the Radcliffe Infirmary. As far as first attacks are concerned, the majority were referred during the first six months. When the relapse group is considered, there was wide variation in the length of history, with many longstanding cases of more than 10 years' duration. Figure 1 shows the number of patients with ulcerative colitis referred to the Radcliffe Infirmary since 1938 by separate five-year periods. It shows a progressive increase in the numbers with the most marked rise during the final period. One cannot conclude from this figure that the incidence of the disease is increasing because many patients with ulcerative colitis are referred from outside the normal catchment area of the hospital, especially recently. For the purpose of the present study, it is important to note that the proportion of first attacks remained remarkably constant throughout, being approximately 40% of the total cases. -1943-1948-1953-1958-62 FIG. 1. The number ofpatients referred to the Radcliffe Infirmary in five-year periods.
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DEATH IN THE FIRST REFERRED ATTACK Table IV shows the proportion of patients in whom the attack of the disease for which the patient was first referred to the Radcliffe Infirmary terminated fatally. During the first decade covered by the study, first-attacks were decidedly more dangerous than relapses, but since 1948 this difference has disappeared. It can also be seen that there has been a progressive diminution in the proportion of fatal cases, the most marked change occurring in 1953, since when the fatality rate has been approximately steady. Such an improvement in short-term prognosis could be the result of various factors, the two most obvious possibilities being changes in treatment and changes in the severity of the disease at the time the patient reached hospital.
SEVERITY OF THE ATTACK The clinical severity of the attack has a profound influence upon short-term prognosis. We have classified each first referred attack into three grades of severity, employing the same criteria as were used in a large-scale therapeutic trial (Truelove and Witts, 1955) , namely: Severe Severe diarrhoea (six or more motions a Apart from cortisone itself, A.C.T.H. was used for a time but has now been almost completely superseded by the modern synthetic analogues of cortisone, such as prednisolone. The systemic use of corticosteroids has been supplemented by local corticosteroid therapy applied by rectal drip since 1955, although initially only a few patients were so treated. Although a series of controlled therapeutic trials has shown these measures to be beneficial in short-term treatment, their introduction into the routine clinical practice of the hospital inevitably lagged behind the formal studies and became the usual form of specific treatment only from about 1958. Any beneficial effects of corticosteroid treatment are therefore only partially shown in the present study.
The other specific therapy, sulphasalazine (Salazopyrin or Asulfidine) only became available in this country in 1955, although used in Sweden from 1940 onwards (Svartz, 1942) . Sulphasalazine has not been used in a major way as specific therapy for ulcerative colitis in Oxford and has usually been employed in combination with corticosteroids. Its use is at present increasing.
In brief, although this type of retrospective study is obviously inferior to a controlled therapeutic trial for assessing the value of specific forms of treatment, it is nevertheless of interest that, since 1953, among the patients who died in their first referred attack of the disease about half had had no specific form of medical treatment (Table VIII) .
Surgery has been employed in only a small proportion of patients in their first referred attack throughout the entire period covered by the study (Table IX) . Any improvement in short-term prognosis cannot be attributed to the more extensive use of surgery. Among those patients treated surgically, the fatality rate has fallen during the period covered by this study, a change which must partly reflect improved surgical technique. Age of the patient The age of the patient has a pronounced effect on the short-term fatality rate, which increases sharply in the older age groups, namely, at 60 years and over. This effect is consistent in first attacks and in relapses, and is statistically significant (Table X and Fig. 4) . It is not due to older patients being more likely to present in a severe attack (Fig. 5) .
There has been no appreciable proportionate increase of patients over the age of 60 in their first referred attack, and the improvement in fatality rate that occurred in the second main period of the study applied as much to them as to younger patients, the proportionate fall being almost identical (results not shown).
Type ofonset The type of onset, whether acute or gradual, has little bearing on the short-term fatality rate (Table XI) . We have confined ourselves to considering patients suffering from their first attack of ulcerative colitis, and we have excluded 29 patients in whom the information was not sufficiently precise to allow of classification.
Length of history As far as first attacks are patients with severe uncomplicated ulcerative colitis died after emergency surgery. In other patients, particular complications of the disease were judged to be the immediate cause of death. In two patients death occurred from unrelated illnesses. There has been a sharp reduction in the number of deaths from uncomplicated ulcerative colitis and this probably reflects improved medical treatment. It has already been shown (Table IX) that there was a small decline in the proportion of patients dealt with by emergency surgery. In effect, virtually the same number of patients was operated on in their first referred attack in each of the two main periods, although the total number of patients seen was much greater in the second period.
Deaths attributed to complications other than carcinoma of the colon also became less frequent. The complications of ulcerative colitis are diverse, but those chiefly liable to cause death in an attack of the disease are perforation of the colon and massive haemorrhage.
OUTCOME OF THE FIRST REFERRED ATTACK
If the patients did not die in the first referred attack, they usually became symptom-free in due course, although the period of time that elapsed before complete remission occurred was very variable. The outcome of the first referred attack is given in Table XV . This deals with the entire series, with the exception of eight patients in whom the immediate course after they left hospital could not be ascertained, although the final outcome was discovered during the course of follow-up.
It is interesting to note that, since 1953, when corticosteroids began to be used, there has been an increase in the proportion of patients who go into complete remission (Table XVI) . Of course, this table gives no information about the time taken to reach complete freedom from symptoms and it is known from controlled therapeutic trials that specific treatment with combined systemic and local corticosteroid therapy greatly increases the chance of rapid remission (Truelove, 1960; Truelove, Watkinson, and Draper, 1962) . In other words, Table XVI almost certainly underestimates the reduction in morbidity which has occurred since 1953.
DISCUSSION
The present study has shown that ulcerative colitis Other Disease remains a formidable disease even in the short term and ignoring the dangers which arise from its being a chronic disorder. Appreciable numbers of patients still die in the attack for which they are referred to hospital. The main factors which lead to a high risk of dying in this attack are a severe clinical picture at the time of referral, extensive disease especially when the whole colon is involved, and the development of a dangerous complication of which perforation of the colon is the chief example; the risk is considerably accentuated if the patient is over the age of 60 years.
In the previous study from this hospital, first attacks were found to be much more dangerous than relapses. In the present study there is not much to choose between them, but it must be emphasized that the earlier study took into consideration all relapses treated in the hospital whereas here we have been concerned only with the first referred attack. If we had included all relapses treated in hospital, we should again find a much lower fatality rate for relapses.
Overall, the short-term fatality rate has shown a considerable improvement during the last decade of the study. This is partly because of the lower proportion of patients severely ill at the time they reach hospital; it is not due to a lower proportion of patients with disease involving the whole colon, which is the same as previously; nor is it due to any decrease in the proportion of patients over 60 years of age at the time of the first referred attack. However, when allowance is made for the change in proportion of severe attacks, there is still evidence of considerable improvement since the introduction of cortisone treatment in 1952, but on analysis this is found to be almost entirely due to a marked improvement in the outcome of patients moderately ill on arrival at hospital. Those severely ill on arrival have shown only a small improvement and they remain as a challenge to the physician.
It must be appreciated that the results of a study such as this, which deals with the total experience of a hospital, are likely to lag behind the changes occurring in specialized units. For example, when cortisone began to be used in this hospital in 1952, it was employed only in the patients admitted to a formal therapeutic trial and even then only half the patients received the drug. It was not until 1954 that this trial was concluded and cortisone or A.C.T.H. began to be used more generally in the treatment of this disease. Local corticosteroid treatment began to be used in 1955 but was at first confined to selected mild or moderate cases (Truelove, 1956 (Truelove, , 1957 . When subsequent controlled trials had shown it to be beneficial in such cases (Truelove, 1958; Watkinson, 1958) it began to be used more extensively but its use in severe attacks of the disease did not begin until 1957. Subsequently the combined use of systemic and local corticosteroid treatment was found to. be advantageous (Truelove, 1960) and as a result this combined corticosteroid treatment has begun to enter general hospital practice. It is therefore plain that the results obtained for the period 1953-62 can be expected to show only a partial reflection of the benefits possible from corticosteroid therapy and a further study will be necessary to evaluate the full effect of this in the general hospital population of ulcerative colitis cases.
The question nevertheless arises whether a severe attack of the disease is not an indication for emergency colectomy. There are few physicians who would contemplate such a step as an immediate procedure in every patient admitted to hospital severely ill with ulcerative colitis. Some surgeons have advocated emergency colectomy in such patients if they do not show swift improvement with a full medical regime, but opinion is divided on how long to wait before resorting to colectomy. For example, Brooke (1956) considered that persistence with corticosteroid therapy in the absence of definite clinical improvement might lead to friability of the entire colon and so prejudice the results of emergency surgery. He concluded that 'steroid therapy should cease in any patient showing no response after one or two weeks', the implication being that they would then be treated by surgery. Lennard-Jones and Vivian (1960) discussed the experience of St. Mark's Hospital and the Central Middlesex Hospital in the management of fulminating ulcerative colitis, by which was implied a very severe attack; unfortunately they did not use a precise definition of a 'fulminating' attack but from their description of the cases, they appear to correspond roughly with our own 'severe' category. Among the 32 patients reviewed, 26 were brought to surgery, with eight deaths (30.8 %). The authors contrast this high operative fatality rate with the low rate after elective surgery in St. Mark's Hospital during the same period. Similarly Goligher (1961) has reported a low fatality rate for elective surgery but a high figure for emergency surgery. The close correspondence between these two surgical series can be seen when the operative fatality rates are tabulated:-Elective Surgery
Lennard-Jones and Vivian (1960) 4.4°/ Goligher (1961) severe attacks, its use should not be continued beyond a specified time limit if there is no sign of a major clinical improvement. Their view of the time limit differs, Lennard-Jones and Vivian taking four days as the period of medical trial, whereas Goligher takes 10 days. Their assumption is that emergency surgery would be less hazardous if performed earlier in the course of the illness than was usual in their cases. This view is strongly pressed by Gallagher, Goulston, Wyndham, and Morrow (1962) who claim that their overall results for severe ulcerative colitis have improved since they adopted the policy of early operation after a short period of intensive treatment usually lasting one to three weeks; among 22 patients so treated, there were only two deaths (91 %).
It must be appreciated that these are all uncontrolled studies and the evidence in favour of early emergency colectomy is far from achieving the weight of scientific proof. The medical treatment of a severe attack of ulcerative colitis is attended by a considerable fatality rate, but emergency colectomy is also dangerous in a patient who is already seriously ill. There thus appears to be an incontrovertible case for a fully controlled therapeutic trial to compare, on the one hand, early emergency colectomy with, on the other hand, a full medical regime in which emergency colectomy is only practised when medical treatment is plainly failing or when there is some complication requiring urgent surgery, such as perforation of the colon.
SUMMARY OF PART I
A study has been made of the clinical course and prognosis in 624 patients treated for ulcerative colitis at the Radcliffe Infirmary between 1938 and 1962 and completely followed-up. In this part of the study we have confined ourselves almost entirely to considering death in the first referred attack.
The chief factors affecting the fatality rate in the first referred attack of the disease were as follows:
SEVERITY OF THE ILLNESS AT TIME OF REFERRAL TO HOSPITAL Patients severely ill had a high chance of dying, patients moderately ill had a much lower but still appreciable risk, whereas patients only mildly ill had a negligible risk.
EXTENT OF THE DISEASE Universal colitis carried the highest risk, involvement of a substantial part of the colon a lower risk, whereas the distal type confined to the rectum and rectosigmoid carried virtually no risk to life. AGE OF THE PATIENT Patients over the age of 60 had a much greater chance of dying than younger patients. This was not because they were more liable to suffer from severe attacks of the disease but because they did not survive such attacks as readily as the younger patients.
There has been a pronounced decline in the overall fatality rate since the introduction of corticosteroid therapy in 1952. This decline is not due to an increase in the employment of radical surgery in the acute attack, although there is evidence of a certain measure of improvement in the operative fatality rate. Part of the decline is due to a lower proportion of the patients being severely ill when reaching hospital in their first attack. When allowance is made for this fact, a substantial improvement can still be shown for the overall results. However, more detailed analysis shows that this improvement comes almost entirely from a sharp improvement in the outcome of the illness in patients moderately ill on arrival at hospital, while patients severely ill on arrival have shown only a small decline in fatality rate.
From the point of view of the short-term course, the finding that severe attacks of the disease continue to carry a considerable fatality rate brings out the main unanswered question of therapy at the present time. This is whether or not an emergency colectomy should be performed with minimal delay in patients who present with such severe attacks. The available published evidence bearing on this issue is briefly discussed and it is concluded that only a fully controlled therapeutic trial would permit of a proper answer.
